Literature DB >> 15158928

Clozapine treatment of a borderline personality disorder with severe self-mutilating behaviours.

Mélanie M Ferreri1, Mélanie M Ferrerri, Jean-Yves Loze, Frédéric Rouillon, Frédéric Limosin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15158928     DOI： 10.1016/j.eurpsy.2003.11.004

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN： 0924-9338            Impact factor:   5.361


× No keyword cloud information.
  7 in total

Review 1.  Pharmacotherapy for borderline personality disorder--current evidence and recent trends.

Authors:  Jutta M Stoffers; Klaus Lieb
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

3.  The novel use of clozapine in an adolescent with borderline personality disorder.

Authors:  Sarah Elizabeth Argent; Simon Alastair Hill
Journal:  Ther Adv Psychopharmacol       Date:  2014-08

4.  Clozapine for self-injurious behavior in individuals with borderline personality disorder.

Authors:  Theodore Zarzar; Joseph McEvoy
Journal:  Ther Adv Psychopharmacol       Date:  2013-10

Review 5.  Medications in the treatment of borderline personality disorder 2006.

Authors:  Deanna Mercer
Journal:  Curr Psychiatry Rep       Date:  2007-02       Impact factor: 8.081

6.  Use of Clozapine for Borderline Personality Disorder: A Case Report.

Authors:  Badii Amamou; Walid Bel Hadj Salah; Ahmed Mhalla; Nejla Benzarti; Hend Elloumi; Ferid Zaafrane; Lotfi Gaha
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 2.582

7.  Second-generation antipsychotic use in borderline personality disorder: What are we targeting?

Authors:  Adrian Wasylyshen; Andrew M Williams
Journal:  Ment Health Clin       Date:  2016-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.